Does DEMCIZUMAB Cause Off label use? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Off label use have been filed in association with DEMCIZUMAB. This represents 7.3% of all adverse event reports for DEMCIZUMAB.
10
Reports of Off label use with DEMCIZUMAB
7.3%
of all DEMCIZUMAB reports
3
Deaths
1
Hospitalizations
How Dangerous Is Off label use From DEMCIZUMAB?
Of the 10 reports, 3 (30.0%) resulted in death, 1 (10.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEMCIZUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does DEMCIZUMAB Cause?
Non-small cell lung cancer (18)
Disease progression (15)
Pancreatic carcinoma metastatic (12)
Drug ineffective (11)
Dehydration (10)
Pancytopenia (10)
Hypotension (8)
Metastases to central nervous system (8)
Metastases to liver (8)
Peroneal nerve palsy (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DEMCIZUMAB Alternatives Have Lower Off label use Risk?
DEMCIZUMAB vs DEMEROL
DEMCIZUMAB vs DENOSUMAB
DEMCIZUMAB vs DEOXYCHOLIC ACID
DEMCIZUMAB vs DEPAKINE CHRONO
DEMCIZUMAB vs DEPAKOTE